Aggressive angiomyxoma of the female pelvis and perineum: A case series

Paul Magtibay, Z. Salmon, Gary Keeney, K. C. Podratz

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Aggressive angiomyxoma (AA) was first described in 1983, and fewer than 150 cases have been reported in the world medical literature. These tumors are benign, locally infiltrative mesenchymal neoplasms with a predilection for the female pelvis and perineum and a tendency to recur. The size of AAs at presentation varies considerably; however, these tumors often achieve large dimensions before becoming clinically symptomatic. Surgical excision remains the mainstay of treatment, but whether clear, tumor-free surgical margins are necessary is controversial. We report a cohort of six patients treated surgically during the past 20 years for primary or recurrent AA. Treatment, surgical margin status, estrogen and progesterone receptor status, and outcomes are reviewed.

Original languageEnglish (US)
Pages (from-to)396-401
Number of pages6
JournalInternational Journal of Gynecological Cancer
Volume16
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Perineum
Myxoma
Pelvis
Neoplasms
Progesterone Receptors
Estrogen Receptors
Therapeutics
Margins of Excision

Keywords

  • Angiomyxoma
  • Estrogen receptor
  • Progesterone receptor

ASJC Scopus subject areas

  • Cancer Research
  • Obstetrics and Gynecology
  • Oncology

Cite this

Aggressive angiomyxoma of the female pelvis and perineum : A case series. / Magtibay, Paul; Salmon, Z.; Keeney, Gary; Podratz, K. C.

In: International Journal of Gynecological Cancer, Vol. 16, No. 1, 01.2006, p. 396-401.

Research output: Contribution to journalReview article

@article{f61eb09d51df40bfa2864f6c17d1b617,
title = "Aggressive angiomyxoma of the female pelvis and perineum: A case series",
abstract = "Aggressive angiomyxoma (AA) was first described in 1983, and fewer than 150 cases have been reported in the world medical literature. These tumors are benign, locally infiltrative mesenchymal neoplasms with a predilection for the female pelvis and perineum and a tendency to recur. The size of AAs at presentation varies considerably; however, these tumors often achieve large dimensions before becoming clinically symptomatic. Surgical excision remains the mainstay of treatment, but whether clear, tumor-free surgical margins are necessary is controversial. We report a cohort of six patients treated surgically during the past 20 years for primary or recurrent AA. Treatment, surgical margin status, estrogen and progesterone receptor status, and outcomes are reviewed.",
keywords = "Angiomyxoma, Estrogen receptor, Progesterone receptor",
author = "Paul Magtibay and Z. Salmon and Gary Keeney and Podratz, {K. C.}",
year = "2006",
month = "1",
doi = "10.1111/j.1525-1438.2006.00225.x",
language = "English (US)",
volume = "16",
pages = "396--401",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Wolters Kluwer Health",
number = "1",

}

TY - JOUR

T1 - Aggressive angiomyxoma of the female pelvis and perineum

T2 - A case series

AU - Magtibay, Paul

AU - Salmon, Z.

AU - Keeney, Gary

AU - Podratz, K. C.

PY - 2006/1

Y1 - 2006/1

N2 - Aggressive angiomyxoma (AA) was first described in 1983, and fewer than 150 cases have been reported in the world medical literature. These tumors are benign, locally infiltrative mesenchymal neoplasms with a predilection for the female pelvis and perineum and a tendency to recur. The size of AAs at presentation varies considerably; however, these tumors often achieve large dimensions before becoming clinically symptomatic. Surgical excision remains the mainstay of treatment, but whether clear, tumor-free surgical margins are necessary is controversial. We report a cohort of six patients treated surgically during the past 20 years for primary or recurrent AA. Treatment, surgical margin status, estrogen and progesterone receptor status, and outcomes are reviewed.

AB - Aggressive angiomyxoma (AA) was first described in 1983, and fewer than 150 cases have been reported in the world medical literature. These tumors are benign, locally infiltrative mesenchymal neoplasms with a predilection for the female pelvis and perineum and a tendency to recur. The size of AAs at presentation varies considerably; however, these tumors often achieve large dimensions before becoming clinically symptomatic. Surgical excision remains the mainstay of treatment, but whether clear, tumor-free surgical margins are necessary is controversial. We report a cohort of six patients treated surgically during the past 20 years for primary or recurrent AA. Treatment, surgical margin status, estrogen and progesterone receptor status, and outcomes are reviewed.

KW - Angiomyxoma

KW - Estrogen receptor

KW - Progesterone receptor

UR - http://www.scopus.com/inward/record.url?scp=33645331582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645331582&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1438.2006.00225.x

DO - 10.1111/j.1525-1438.2006.00225.x

M3 - Review article

C2 - 16445665

AN - SCOPUS:33645331582

VL - 16

SP - 396

EP - 401

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 1

ER -